A Top 5 consumer health company has pledged to meet all safety and environmental standards while maintaining the efficacy that their brand has historically delivered. Accomplishing this will require reformulation of more than 200 consumer products within 2 years, without affecting the brand image.
The Rx-to-OTC market in U.S. has grown into a $7.8 billion market. Are you ready to make the switch? This white paper discusses the Rx-to-OTC process, challenges, strategies and the roadmap for pharmaceutical companies to execute a successful switch.
Follow iMEDGlobal on LinkedIn for the latest on global product development. Read breaking stories, editorials by key opinion leaders, and articles by and/or about iMEDGlobal.